As expected, a gradient of increasing tau positivity probabilities was observed from quartile 4 to quartile 1 across all AD variants (Fig. 4A–E; paired Wilcoxon signed-rank tests indicating P < 0.05 for all quartile comparisons). This evidence concerns the gene MAPT and Alzheimer disease.